PALLAS: A randomized phase III trial of adjuvant palbociclib with endocrine therapy versus endocrine therapy alone for HR+/HER2- early breast cancer



- Citation:
- Annals of Oncology vol 31 (Supplement 4) S1145
- Meeting Instance:
- ESMO 2020
- Year:
- 2020
- Type:
- Abstract
- Sub type:
- Published Only
- Funding:
- AFT
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- epub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- Yes
- Parents:
- None
- Children:
- 3408